Organ Transplantation clinical trials

Explore recruiting organ transplantation clinical trials.

Recruiting organ transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Organ Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immunosuppressive drug bioequivalence in kidney transplant recipients – Prograf and CellCept

Norway

Therapeutic use (Phase IV) EU CTIS Study details

A Phase I/IIa open label single ascending dose study to investigate the safety and tolerability of regulatory T cells as an adjunctive therapy in deceased-donor kidney recipients - ProTreg

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression

Sweden

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

A Phase I/IIa open label single ascending dose study to assess safety and tolerability of regulatory T cells to promote discontinuation of tacrolimus monotherapy in liver transplant recipients - LiveTreg

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

HepaStem Long-Term Safety Registry – Registry for Patients who have been administered HepaStem

Spain, Belgium, France, Bulgaria, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicentre, open-label, randomised, two-arm, parallel-group, superiority trial to assess bioavailability and practicability of two once-daily tacrolimus formulations, Envarsus® compared with Advagraf™, administered in kidney transplant recipients

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Organ Transplantation trials by city

Organ Transplantation in Toronto Organ Transplantation in Vancouver Organ Transplantation in Montreal Organ Transplantation in Calgary Organ Transplantation in Edmonton Organ Transplantation in Ottawa Organ Transplantation in Winnipeg Organ Transplantation in Quebec City Organ Transplantation in Hamilton Organ Transplantation in Kitchener Organ Transplantation in London Organ Transplantation in Halifax Organ Transplantation in New York Organ Transplantation in Los Angeles Organ Transplantation in Chicago Organ Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease